Multi-omics integrative modelling for stereotactic body radiotherapy in early-stage non-small cell lung cancer: Clinical trial protocol of the MONDRIAN study

Currently, main treatment strategies for early-stage non-small cell lung cancer (ES-NSCLC) disease are surgery or stereotactic body radiation therapy (SBRT), with successful local control rates for both approaches.